Natera Acquires Invitae’s Prenatal Screening Business
Market News

Natera Acquires Invitae’s Prenatal Screening Business

Natera (NTRA) has released an update.

Natera, Inc. announced the acquisition of assets related to Invitae Corporation’s non-invasive prenatal screening and genetic carrier screening business on January 22, 2024. A press release detailing the acquisition was filed with the relevant regulatory documents.

For further insights into NTRA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyClosing Bell Movers: Instacart down 6% after earnings
TheFlyNatera reports Q3 EPS (26c), consensus (57c)
TheFlyNatera raises FY24 revenue view to $1.61B-$1.64B from $1.49B-$1.52B
Go Ad-Free with Our App